Actor Dolph Lundgren Achieved Cancer-Free Status in 2024
After years of misdiagnosis, a refined genetic testing approach helped clear tumors for the actor.
Updated on Sept. 23, 2026 in Cancer
Actor Dolph Lundgren announced he was cancer-free in 2024 following a multi-year medical journey. His recovery followed a critical pivot in his treatment plan after an oncologist at UCLA Health discovered a specific mutation in his tumor cells.
Why it matters
Lundgren's experience highlights the vital role of seeking a second opinion when initial therapies fail to produce results. This case underscores how identifying the specific genetic profile of a tumor can fundamentally change a treatment strategy.
Clinical findings showed a 90% reduction in tumor burden by 2022 after systemic therapy was adjusted to target a specific mutation. This outcome followed an initial period of tumor growth where standard kidney cancer protocols were unsuccessful.
The players
Dolph Lundgren
An actor who shared his medical experience to highlight the importance of accurate diagnostic testing.
Dr. Alexandra Drakaki
An oncologist at UCLA Health who identified the genetic mutation underlying the patient's tumors.
UCLA Health
A major academic medical center in Los Angeles that provides specialized oncological research and care.
The details
Lundgren’s care was transformed when Dr. Alexandra Drakaki identified a genetic mutation in his tumor cells common in lung cancer, rather than the kidney cancer he was originally treated for. By shifting to a treatment regimen targeting this specific mutation, physicians were able to facilitate significant tumor shrinkage, which was eventually supplemented by a minimally invasive lung ablation procedure.
Timeline
2015: Lundgren was initially diagnosed with kidney cancer and underwent tumor removal surgery.
2020: Six tumors were removed, and a new tumor the size of a small lemon was identified in his liver.
May 2023: Lundgren spoke publicly about his health status for the first time.
2024: Lundgren declared he was cancer-free.
September 2025: Lundgren confirmed that medical assessments showed no evidence of disease.
Health Landscape
This case illustrates the clinical move toward precision oncology and biomarker-driven therapy, where genetic profiling replaces tissue-of-origin as the primary guide for systemic treatment. It highlights a shift in modern medicine where diagnostic accuracy through molecular testing is increasingly central to improving survival rates.
If you are managing a persistent condition and not seeing progress, discuss with your doctor whether advanced genomic or molecular testing might offer new insights into your diagnosis. Seeking a second opinion at an academic medical center can be a practical step when standard protocols are ineffective.
The takeaway
An accurate diagnosis is the most critical foundation for effective cancer treatment. If a treatment plan is not working as expected, consult with your physician about whether additional testing could reveal new information about your underlying health condition.
Further reading
For more information on diagnostic advancements, visit Cancer.
Source note: This article includes information reported by People.
